Challenges with Solubility and Bioavailability Video, Part 3

Jun 21, 2013
By Pharmaceutical Technology Editors

Recorded live at the Interphex 2013 trade show, Rita Peters asks Jeffery C. Basham, vice president, business development: From your experience, do you find that the related project work for solubility/bioavailability enhancement is mostly applied for new drug development or do you see it also driving growth in projects for product lifecycle management, for example, to improve dosing schemes/regimes? Can you provide an example of either case?

Check out the rest of the interview:

Part 1

Part 2

lorem ipsum